Weilong Shi Selected Research

Weilong Shi Research Topics

2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 10/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018 - 10/2017
1	Heart Failure 01/2022
1	Basal Cell Carcinoma (Rodent Ulcer) 02/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2019
1	Stroke (Strokes) 01/2019
1	Ischemic Stroke 01/2019
1	Body Weight (Weight, Body) 01/2018
1	Infections 01/2018
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2017
1	Neoplasms (Cancer) 10/2017
1	Poisoning 06/2017

3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 10/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 10/2017
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Voriconazole (Vfend)FDA LinkGeneric 02/2019
1	Capsules (Microcapsules)IBA 01/2019
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018
1	SymportersIBA 01/2018
1	Pioglitazone (Actos)FDA Link 01/2018
1	CholesterolIBA 01/2018
1	HDL LipoproteinsIBA 01/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018
1	SodiumIBA 01/2018
1	empagliflozinIBA 10/2017
1	CanagliflozinIBA 10/2017
1	Sodium-Glucose Transport ProteinsIBA 10/2017
1	carboxyl radical (COO-)IBA 06/2017

1	Therapeutics 01/2018